Junli Fan
Overview
Explore the profile of Junli Fan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
1119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serological proteomic profiling uncovered CDK5RAP2 as a novel marker in benign prostatic hyperplasia
Xie H, Fan J, Wang J, Liu T, Chen L, Pan Y, et al.
Clin Biochem
. 2024 Dec;
135():110867.
PMID: 39694406
Background: Benign prostatic hyperplasia (BPH) affects approximately half of men over the age of 50. Early detection and timely treatment facilitate disease intervention and achieve a better clinical outcome. However,...
2.
Gao X, Wang A, Fan J, Zhang T, Li C, Yue T, et al.
J Sports Med Phys Fitness
. 2024 Jul;
64(11):1147-1156.
PMID: 39023202
Background: Ischemic preconditioning (IPC) has been suggested to improve exercise performance by 1-8%. Prior research concerning its impact on short-duration exercises, such as sprints, has been limited and yielded conflicting...
3.
Wang G, Fan J, Yue T, Gao X, Zhang T, Hurr C
Eur J Appl Physiol
. 2024 May;
124(10):3095-3103.
PMID: 38819660
Purpose: Exposure to cold temperatures decreases finger temperature (T) and dexterity. Decreased manual function and dexterity can be serious safety risks, especially in tasks that require fine motor movements that...
4.
Li S, Zeng H, Fan J, Wang F, Xu C, Li Y, et al.
Biochem Pharmacol
. 2023 Feb;
210:115464.
PMID: 36849062
Cancer is characterized by metabolic reprogramming, which is a hot topic in tumor treatment research. Cancer cells alter metabolic pathways to promote their growth, and the common purpose of these...
5.
Xu C, Zeng H, Fan J, Huang W, Yu X, Li S, et al.
BMC Cancer
. 2022 Mar;
22(1):264.
PMID: 35279104
Background: With the improved knowledge of disease biology and the introduction of immune checkpoints, there has been significant progress in treating renal cell carcinoma (RCC) patients. Individual treatment will differ...
6.
Sun K, Wang H, Xu X, Wei X, Su J, Zhu K, et al.
Front Oncol
. 2021 Oct;
11:736412.
PMID: 34692511
Aims: To evaluate the value of tumor-educated platelet (TEP) miR-18a-3p in the early diagnosis and chemotherapy efficacy monitoring of nasopharyngeal carcinoma (NPC). Methods: Expression levels of miR-18a-3p in platelets and...
7.
Xu C, Fan J, Luo Y, Zhao Z, Tang P, Yang G, et al.
J Inflamm Res
. 2021 Jul;
14:3123-3128.
PMID: 34285538
Objective: Patients with rheumatic immune diseases were more likely to develop severe or critical COVID-19. We aimed to determine whether rheumatoid factor antibodies were present in COVID patients and the...
8.
Tang Y, Sun J, Pan H, Yao F, Yuan Y, Zeng M, et al.
Cytokine
. 2021 Apr;
143:155523.
PMID: 33840589
Cytokines play pleiotropic, antagonistic, and collaborative in viral disease. The high morbidity and mortality of coronavirus disease 2019 (COVID-19) make it a significant threat to global public health. Elucidating its...
9.
Mo P, Deng L, Liu X, Gao S, Liang K, Luo M, et al.
Epidemiol Infect
. 2020 Dec;
148:e293.
PMID: 33256876
The epidemic of coronavirus disease 2019 (COVID-19) began in China and had spread rapidly to many other countries. This study aimed to identify risk factors associated with delayed negative conversion...
10.
Pan Y, Li X, Yang G, Fan J, Tang Y, Hong X, et al.
Clin Microbiol Infect
. 2020 Oct;
27(2):253-257.
PMID: 33035672
Objectives: The outbreak of the 2019 coronavirus disease (COVID-19) pandemic in Wuhan, China, has subsided after being hard hit by the disease and subsequent city lockdown. Information on the number...